G. Sotgiu (Sassari, Italy), D. Falzon (Geneva, Switzerland)
Time trends in multidrug-resistant tuberculosis
D. Falzon, M. Zignol (Geneva, Switzerland)
|  |
Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
A. Skrahina, H. Hurevich, A. Zalutskaya, E. Sahalchyk, A. Astrauko, S. Hoffner, V. Rusovich, A. Dadu, P. de Colombani, M. Dara, W. Van Gemert, M. Zignol (Minsk, Belarus; Stockholm, Sweden; Copenhagen, Denmark; Geneva, Switzerland)
|  |
Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis
A. Altraja, P. Viiklepp, L. Pehme (Tallinn, Tartu, Estonia)
| |
Is multidrug-resistant TB more common in children? An analysis of surveillance data
D. Falzon, M. Zignol, C. Sismanidis, P. Glaziou (Geneva, Switzerland)
| |
Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics
D. Masoud, M. Zignol, D. Falzon (Geneva, Switzerland; Copenhagen, Denmark)
| |
Rational use of tuberculosis drugs to prevent the development of drug resistance
E. Huitric, M. J. van der Werf, M. W. Langendam, L. D‘Ambrosio, R. Centis, F. Blasi, G. B. Migliori, D. Manissero (Stockholm, Sweden; The Hague, Netherlands; Tradate, Milan, Italy)
| |
ECDC guidance on management of contacts of MDR-TB and XDR-TB patients
A. Sandgren, M. van der Werf (Stockholm, Sweden)
|  |